
Prescriva Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: people who want compounded semaglutide or tirzepatide with the pharmacy names published up front
Prescriva scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Prescriva's site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Prescriva is a Sacramento telehealth platform that sells compounded semaglutide and tirzepatide, with prescribing by OpenLoop Health clinicians and three named compounding pharmacies. Plans cost $249 for semaglutide injections, $279 for semaglutide tablets and $339 for tirzepatide, charged every 4 weeks rather than monthly.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Prescriva
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Prescriva at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/4 wks (billed per 4 weeks)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Prescriva
Each dimension is scored algorithmically from Prescriva'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.2/10Prescriva's headline is $249 every 4 weeks. Compare it with other programs on the same plan basis.
Effectiveness25%
8.2/10Prescriva offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.5/10Prescriva's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.9/10Prescriva provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Prescriva review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $249–$339 per 4 weeks across 3 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Prescriva
We walked Prescriva's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Check Eligibility opens a one-question screen asking whether you are enrolled in Medicare
- 2One form asks for name, date of birth, sex, height, weight, email, mobile phone, state and ZIP, and shows your BMI
- 3Two checkboxes are required to continue: consent to text messages and an auto-renewal acknowledgment
- 4About 15 health screens cover goals, medical conditions, past weight-loss medicine, current medications, blood pressure and heart rate
- 5After you submit, a plan page lets you pick the medication and a 4, 12, 24 or 48-week supply
- 6A secure card checkout shows the amount due today and the 28-day billing cycle (walk stopped here)
- Plan prices are on the website, and the same $249, $279 and $339 figures appear at checkout
- The checkout reads "Billed every 28 days" and the plan page says "billed every 4 weeks", while the site and intake say monthly
- Payment is taken at checkout; the consent page says a clinician consults with you after checkout
- Longer supplies are one upfront charge: $2,327 for 48 weeks of semaglutide injections
- The microdose intake asks you to agree to get GLP-1 medicine only through this platform, and answering no ends the assessment
- Text-message consent is required to continue past the first form
- We did not take the medication; nothing here describes a patient outcome
Prescriva customer support
- Phone
- (888) 808-0343
GLP-1 medications Prescriva offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Charged every 28 days (13 charges a year). 12, 24 and 48-week supplies cost $657, $1,194 and $2,327, each paid upfront
Charged every 28 days. 12, 24 and 48-week supplies cost $777, $1,434 and $2,717, each paid upfront
Charged every 28 days (13 charges a year). 12, 24 and 48-week supplies cost $927, $1,734 and $3,497, each paid upfront
Ready to get started?
Plans and promotions change often, so check Prescriva's current pricing and active discounts before you decide.
What we like
- Names its medical group, OpenLoop Health, and all three dispensing pharmacies with addresses in its terms
- Injection plan prices are listed on the site before you start the assessment
- The price covers the clinician visit, the medication and free priority shipping, with no separate membership fee
- Offers semaglutide as a weekly injection or a daily dissolving tablet, plus tirzepatide injections
- You get a full refund of the current charge if the clinician decides treatment is not right for you
- You can cancel or pause from your patient dashboard, with no cancellation fee
- Publishes a support phone number, and HSA or FSA cards are accepted
Watch-outs
- Plans are charged every 4 weeks, so a year brings 13 charges rather than 12, though the site says per month
- The $194 semaglutide figure is a 48-week supply paid upfront at $2,327 and divided by 12, not a monthly price
- The pricing page also shows a $109 starting price and a $289 semaglutide price that match no plan in checkout
- You pay at checkout before a clinician reviews your answers
- Refunds stop once a clinician consultation is completed or medication ships, and partial cycles are not refunded
- The intake requires you to agree to text messages before you can continue
- The intake shows an "Excellent 4.9" rating with no source, while the company's review profile has no reviews yet
- The terms say service is offered in all 50 states, but the FAQ says most states
Is Prescriva worth it?
Prescriva is built for people who want compounded semaglutide or tirzepatide with the pharmacy names published up front. It runs $249 every 4 weeks. The cost section below explains how that price is billed and what it covers, so you can line it up against other programs on the same basis. Its standout is a needle-free oral option for people who would rather not inject.
Beyond the medication itself, Prescriva takes HSA/FSA payment.
How much Prescriva costs
Compounded semaglutide runs $249–$279 every 4 weeks depending on plan; the low end is $249 every 4 weeks and compounded tirzepatide runs $339 every 4 weeks.
Prescriva's headline figure is $249 every 4 weeks, which is how the price is listed on its own site. When you compare it with the alternatives below, line them up on the same billing basis and check what each plan includes.
RxSpan MD (about $249/month) is one of the closest alternatives to weigh Prescriva against.
Medications: what Prescriva prescribes
Prescriva prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Prescriva's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: compounded oral, sublingual and buccal versions of these peptides are far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Prescriva is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want the medication and clinician care, plus shipping, covered by one price instead of billed separately.
- want both semaglutide and tirzepatide on the menu, so you can change molecules without changing providers.
- plan to pay with an HSA or FSA card.
Look elsewhere if you…
- specifically want FDA-approved brand-name medication instead of a compounded formulation, since this provider lists no brand-name price.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Prescriva is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see Prescriva against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Prescriva scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Prescriva?
From $249 every 4 weeks. See current pricing and start your online intake.
Prescriva might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Prescriva vs…
Prescriva scores7.0/10
Side-by-side pricing, medications and scores. Pick a matchup.
Prescriva vs Amazon One Medical
Amazon One Medical scores 8.5/10

Prescriva vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Prescriva review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Prescriva's current pricing
Plans from $249 every 4 weeks. Start the online intake to check eligibility and today's price.